RE: TheoremRx10 Jan 2025 17:40
@Trench123
And THX have made countless empty proposals that have come to nothing. It was the NASDAQ listed company EUDA before that and that also came to nothing and i highly suspect its because it fails at the Due Diligence stage. Look you are talking about a 15yr+ peptide in 201. It needs reformulating, it needs new patents, it needs loads of work and that's of course if its even viable to still do so as the technology has likely been superseded long ago. Meanwhile, THX themselves have next to zero credibility IMO. What evaluations have they previously taken from start up to commercialisation? Further, as i pointed out before, even in in the unlikely chance THX got funded, which IMO they won't, they would owe it to the new investors to renegotiate terms. Nobody but nobody in this market chucks massive amounts of cash in upfront deals, it is just not happening and there are loads of great biotechs out there competing for cash. Sorry but 201 isn't one of them. Now i have no idea why ME is even still allowing THX to continue with this nonsense BUT from a value point of view its probably better for ME to keep the dream alive than kill it off. My call is that come end of May they still wont complete and maybe just maybe ME will finally see the light, penny will drop and call time on it.
@PM2022
I would agree that CLX has potential. BUT its a long, long way off. Probably three or four more discounted raises from here, especially with the obscene admin costs that continue. So whilst i share your enthusiasm regarding its potential, the chance of VAL seeing any actual licensed cash from it anything in the next could of years are slim if at all. That's how i see it. And as for 401, well Ambrose need cash to keep themselves going so you wont be seeing any meaningful cash from them anytime soon IMO either.
Appreciate that both cheerleaders @PM2022 and @Laura2022 will keep pumping this morning noon and night but sorry, all that will happen here is the further erosion of cash to support lifestyles and back come September for another discounted raise. Its how i see it.
@laura2022
As for your NT to buy nonsence. Take it from me, you could buy £1m of stock at .65 if you so desired. Anyone with any sense would sell at .65 and just keep the warrants, in for no risk then. Meanwhile this remains a traders stock only. I highly suspect you will get a chance to buy in at .40 to .50 very shortly. The amount of stock to clear at .65 is absolutely ridiculous. I wouldn't be surprised if ME calls for a consolidation event again before September to get the share volume back to a more manageable level.
Meanwhile, keep pumping...